Engineers Gate Manager LP Enveric Biosciences, Inc. Transaction History

Engineers Gate Manager LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$12.5 - $52.0 $87,850 - $365,456	-7,028 Reduced 21.39%	25,824 $9,000
Q4 2021 Feb 14, 2022	BUY	$46.5 - $104.0 $190,231 - $425,464	4,091 Added 14.22%	32,852 $31,000
Q3 2021 Nov 15, 2021	SELL	$80.5 - $175.0 $130,329 - $283,325	-1,619 Reduced 5.33%	28,761 $60,000
Q2 2021 Aug 16, 2021	SELL	$95.0 - $156.5 $827,925 - $1.36 Million	-8,715 Reduced 22.29%	30,380 $72,000
Q1 2021 May 17, 2021	BUY	$131.5 - $245.0 $5.14 Million - $9.58 Million	39,095 New	39,095 $120,000

Ticker ENVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,078,270
Market Cap $11.8M
Description
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.